Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331678 · ClinicalTrials.gov registry record · NA
Evaluation of a Mobile App to Promote Social Support for Oncology Patients
A NA study of Chemotherapy Effect, sponsored by West Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 3
- Study locations
NCT04331678: Completed NA study of Chemotherapy Effect, sponsored by West Cancer Center.
NCT04331678 is a NA study of Chemotherapy Effect that has completed, run by West Cancer Center. The registered enrollment target is 230 participants, above the 71-participant average among 7 other Chemotherapy Effect trials with a reported enrollment target (224% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04331678, a NA study of Chemotherapy Effect, has completed, sponsored by West Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 3
- Study locations
Study Summary
Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.
Primary Outcome
a. Investigators will measure the relative changes in functional status of cancer patients using the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire. FACT-G is a 27-item questionnaire asking participants to report the four primary QoL domains, including physical, social/family, emotional and functional well-being on a 5-point Likert scale where 0 = Not at all to 4 = Very much with higher scores representing better general QoL.
Conditions Studied
Interventions
- BEHAVIORAL Comparator App
Study Locations (3)
Tennessee
- West Cancer Center - Germantown
- West Cancer Center - Memphis
Mississippi
- West Cancer Center - Southaven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2021-10-24 |
| Phase | NA |
What the finished NCT04331678 record still lists
NCT04331678 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, above the 71-participant average among 7 other Chemotherapy Effect trials with a reported enrollment target (224% higher).
The record links to 1 condition, with Chemotherapy Effect appearing as the primary indexed condition, and to 1 intervention - of which Comparator App is the first listed.
NCT04331678 reports a single indexed study location in Tennessee, Mississippi.
Frequently Asked Questions
What is clinical trial NCT04331678 about?
NCT04331678 is a clinical study titled "Evaluation of a Mobile App to Promote Social Support for Oncology Patients". Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.
What is the current status of trial NCT04331678?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2020-03-12. Estimated completion is 2021-10-24.
What conditions does trial NCT04331678 study?
This clinical trial studies the following conditions: Chemotherapy Effect.
What interventions are being tested in trial NCT04331678?
The interventions under investigation include: Comparator App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04331678?
This trial is sponsored by West Cancer Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04331678 being conducted?
This trial has 3 study locations across Mississippi, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy Effect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improve Cancer-related Cognitive Impairment
RECRUITING · NA
-
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
RECRUITING · NA
-
FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
COMPLETED · NA
-
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI